Literature DB >> 3297960

New ideas in thyroid autoimmunity.

R Pujol-Borrell, I Todd, M Londei, M Feldmann, G F Bottazzo.   

Abstract

Endocrine epithelial cells do not normally express human leukocyte antigen (HLA) class II molecules, but do so in a variety of autoimmune diseases. This finding suggests the hypothesis that such inappropriate class II-positive expression may enable these cells to present autoantigens and thus contribute to autoimmune pathogenesis. Indeed, class II-positive thyrocytes can present both exogenous antigenic peptides and intrinsic autoantigens to the appropriate T cells. Class II expression by thyrocytes can be induced by interferon-gamma, and is positively and negatively regulated by thyroid-stimulating hormone and epidermal growth factor, respectively. Furthermore, heterogeneity of thyrocyte class II subregion expression appears to be related to the nature of the inducing stimulus. The complexity of regulatory signals is underlined by findings in type I diabetes: islet beta cells aberrantly express class II in this disease, but class II cannot be induced in normal beta cells by interferon-gamma.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3297960     DOI: 10.1159/000180690

Source DB:  PubMed          Journal:  Horm Res        ISSN: 0301-0163


  3 in total

1.  Thyrotropin modifies activation of nuclear factor kappaB by tumour necrosis factor alpha in rat thyroid cell line.

Authors:  T Kikumori; F Kambe; T Nagaya; H Funahashi; H Seo
Journal:  Biochem J       Date:  2001-03-15       Impact factor: 3.857

2.  One-tube-PCR technique for CCL2, CCL3, CCL4 and CCL5 applied to fine needle aspiration biopsies shows different profiles in autoimmune and non-autoimmune thyroid disorders.

Authors:  X Ferrer-Francesch; P Caro; L Alcalde; M P Armengol; Y Ashhab; A Lucas-Martín; E M Martínez-Cáceres; M Juan; R Pujol-Borrell
Journal:  J Endocrinol Invest       Date:  2006-04       Impact factor: 4.256

Review 3.  Role of apoptosis in autoimmunity.

Authors:  Matilde Todaro; Ann Zeuner; Giorgio Stassi
Journal:  J Clin Immunol       Date:  2004-01       Impact factor: 8.542

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.